Breast Cancer Clinical Trials in Boston, MA

Breast Cancer Clinical Trials in Boston, MA

View the best 10 breast cancer medical studies in Boston, Massachusetts. Access promising new therapies by applying to a Boston-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in Boston, Massachusetts

Here are the top 10 medical studies for breast cancer in Boston, Massachusetts

Image of Massachusetts General Hospital in Boston, United States.

Ribociclib

CDK 4/6 Inhibitor

Recruiting3 awardsPhase 2
This trial is testing whether the drug can help to treat ER-positive Breast Cancer.
Image of Massachusetts General Hospital in Boston, United States.

ARM 1

Recruiting1 award10 criteria
This trial looks at how well chemotherapy affects cognition and the brain in people with breast cancer.
Image of Boston Medical Center in Boston, United States.

Diffuse Optical Spectroscopy Imaging (DOSI)

Imaging Technology

Recruiting1 award9 criteria
This trial is testing whether an investigational imaging technology called DOSI can predict how well breast cancer patients will respond to chemotherapy treatment. DOSI is a noninvasive imaging method that uses harmless near-infrared light and requires no external contrast agent.
Image of Dana Farber Cancer Institute in Boston, United States.

Olaparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 1
This trial is attempting to find a more effective treatment for breast cancer, specifically for those with a BRCA mutation. The study will be testing a combination of two drugs, sapacitabine and olaparib, to see if they are more effective than either drug used alone.
Image of University of California, San Francisco in San Francisco, United States.

Atorvastatin +1 More

HMG-CoA reductase inhibitor

Recruiting2 awardsPhase 2
This trial is testing whether the cholesterol-lowering medication atorvastatin can reduce the risk of breast cancer.
Image of Dana-Farber Cancer Institute in Boston, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is studying how well chemotherapy and immunotherapy work in treating hormone receptor positive breast cancer.
Image of VA Boston Healthcare System in Boston, United States.

Polygenic risk score (PRS)

Polygenic Risk Score

Recruiting1 award1 criteria
This trial will test how well polygenic risk score testing works in patients who are at high genetic risk for certain diseases.
Image of Kaiser Permanente-Deer Valley Medical Center in Antioch, United States.

Carvedilol

Recruiting2 awardsPhase 3
This trial studies the effects of carvedilol on preventing heart problems in patients with HER2-positive breast cancer.
Image of AIS Cancer Center at San Joaquin Community Hospital in Bakersfield, United States.

Axillary Lymph Node Dissection (ALND) +1 More

N/A

Recruiting2 awardsPhase 3
This trial is comparing radiation therapy alone to radiation therapy with lymph node dissection in treating breast cancer patients who have already had chemotherapy and surgery.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Surgery +2 More

Procedure

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.

Popular filter options for breast-cancer boston trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

View More Breast-cancer Boston Trials

See another 85 medical studies focused on breast-cancer boston.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.